Maurer, M. S., & Kristen, A. (2018). Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. The New England journal of medicine, 379(11), . https://doi.org/10.1056/NEJMoa1805689
Chicago Style (17th ed.) CitationMaurer, Mathew S., and Arnt Kristen. "Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy." The New England Journal of Medicine 379, no. 11 (2018). https://doi.org/10.1056/NEJMoa1805689.
MLA (9th ed.) CitationMaurer, Mathew S., and Arnt Kristen. "Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy." The New England Journal of Medicine, vol. 379, no. 11, 2018, https://doi.org/10.1056/NEJMoa1805689.
Warning: These citations may not always be 100% accurate.